{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:14:51Z","timestamp":1790338491253,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.radonc.2004.12.012","type":"journal-article","created":{"date-parts":[[2005,3,16]],"date-time":"2005-03-16T07:14:06Z","timestamp":1110957246000},"page":"18-21","source":"Crossref","is-referenced-by-count":116,"title":["TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer"],"prefix":"10.1016","volume":"75","author":[{"given":"Christian Nicolaj","family":"Andreassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Alsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Herskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Haviland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis","family":"Homewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Bliss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Yarnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2004.12.012_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0167-8140(02)00154-8","article-title":"Does variability in normal tissue reactions after radiotherapy have a genetic basis\u2014where and how to look for it?","volume":"64","author":"Andreassen","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2004.12.012_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.radonc.2003.09.010","article-title":"Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes","volume":"69","author":"Andreassen","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2004.12.012_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.radonc.2004.07.006","article-title":"Optimisation and validation of methods to assess single nucleotide polymorphisms (SNPs) in archival histological material","volume":"72","author":"Andreassen","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2004.12.012_bib4","first-page":"8717","article-title":"ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity","volume":"63","author":"Angele","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2004.12.012_bib5","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/00007890-199810270-00009","article-title":"Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation","volume":"66","author":"Awad","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.radonc.2004.12.012_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.radonc.2003.08.006","article-title":"Towards genetic prediction of radiation responses: ESTRO's GENEPI project","volume":"69","author":"Baumann","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2004.12.012_bib7","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0360-3016(03)00188-3","article-title":"Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed","volume":"56","author":"Dikomey","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2004.12.012_bib8","first-page":"2610","article-title":"A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer","volume":"63","author":"Dunning","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2004.12.012_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0167-8140(02)00079-8","article-title":"Variation in the manganese superoxide dismutase gene (SOD2) is not a major cause of radiotherapy complications in breast cancer patients","volume":"63","author":"Green","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2004.12.012_bib10","first-page":"385","article-title":"A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy","volume":"4","author":"Hall","year":"1998","journal-title":"Cancer J Sci Am"},{"key":"10.1016\/j.radonc.2004.12.012_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0167-8140(01)00457-1","article-title":"Quantification of late complications after radiation therapy","volume":"61","author":"Jung","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2004.12.012_bib12","first-page":"1168","article-title":"Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy","volume":"12","author":"Moullan","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.radonc.2004.12.012_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0167-8140(00)00173-0","article-title":"Cellular radiosensitivity and complication risk after curative radiotherapy","volume":"55","author":"Peacock","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2004.12.012_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/713865032","article-title":"Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients","volume":"79","author":"Quarmby","year":"2003","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2004.12.012_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0167-8140(04)81921-2","article-title":"Possible correlation between the ATM codon 1853 ASP\/ASN polymorphism and risk of radiation-induced fibrosis (meetings abstract ESTRO 23)","volume":"73","author":"Rosenstein","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2004.12.012_bib16","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/bjc.1998.602","article-title":"Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients","volume":"78","author":"Shayeghi","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2004.12.012_bib17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1042\/CS19980154","article-title":"Transforming growth factor-beta1 gene polymorphisms and coronary artery disease","volume":"95","author":"Syrris","year":"1998","journal-title":"Clin Sci (London)"},{"key":"10.1016\/j.radonc.2004.12.012_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","article-title":"Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial","volume":"75","author":"Yarnold","year":"2005","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814004005766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814004005766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T21:53:42Z","timestamp":1548626022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814004005766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0167814004005766"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2004.12.012","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}